CAR T-cell therapies in China: rapid evolution and a bright future.
Hu Y, Feng J, Gu T, Wang L, Wang Y, Zhou L, Hong R, Tan Su Yin E, Zhang M, Lu P, Huang H.
Hu Y, et al. Among authors: feng j.
Lancet Haematol. 2022 Dec;9(12):e930-e941. doi: 10.1016/S2352-3026(22)00291-5.
Lancet Haematol. 2022.
PMID: 36455608
Review.